Ionis Pharmaceuticals Inc... (IONS)
NASDAQ: IONS
· Real-Time Price · USD
43.45
0.60 (1.40%)
At close: Aug 15, 2025, 1:11 PM
1.40% (1D)
| Bid | 43.4 |
| Market Cap | 6.93B |
| Revenue (ttm) | 944.24M |
| Net Income (ttm) | -268.22M |
| EPS (ttm) | -1.76 |
| PE Ratio (ttm) | -24.69 |
| Forward PE | -13.25 |
| Analyst | Buy |
| Ask | 43.5 |
| Volume | 454,819 |
| Avg. Volume (20D) | 1,851,256 |
| Open | 42.86 |
| Previous Close | 42.85 |
| Day's Range | 42.80 - 43.48 |
| 52-Week Range | 23.95 - 50.43 |
| Beta | 0.25 |
About IONS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IONS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IONS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Ionis Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+4.56%
Ionis Pharmaceuticals shares are trading higher af...
Unlock content with
Pro Subscription
1 month ago
+9.14%
Ionis Pharmaceuticals shares are trading higher on possible continued strength after Barclays upgraded the stock yesterday from Equal-Weight to Overweight and raised its price target from $51 to $57.
